Agence de la santé publique du Canada
Symbole du gouvernement du Canada
Passer au contenu | Passer aux liens institutionnels

Liens de la barre de menu commune

Accueil > Influenza > Plan canadien de lutte contre la pandémie d'influenza dans le secteur de la santé > Prévention et contrôle de la grippe durant une pandémie pour tous les milieux de soins

Prévention et contrôle de la grippe durant une pandémie pour tous les milieux de soins

[Page précédente] [Table des matières]

Références

  1. Agence de la santé publique du Canada (auparavant Santé Canada). Guide de prévention des infections pour la prévention et la lutte contre les infections professionnelles dans le domaine de la santé. Relevé des maladies transmissibles au Canada 2002;28S1:1-264.
  2. Agence de la santé publique du Canada (auparavant Santé Canada). Guide de prévention des infections : Pratiques de base et précautions additionnelles visant à prévenir la transmission des infections dans les établissements de santé. Relevé des maladies transmissibles au Canada 1999;25S4:1-142.
  3. Agence de la santé publique du Canada. Pratiques de base et précautions additionnelles visant à prévenir la transmission des infections dans les milieux de soins (sous presse). 2011.
  4. Agence de la santé publique du Canada. Lignes directrices pour la prévention et le contrôle des infections : Lignes directrices de prévention de la pneumonie associée aux soins de santé (sous presse). 2011.
  5. Agence de la santé publique du Canada. Plan canadien de lutte contre la pandémie d’influenza dans le secteur de la santé. 2006 (cité le 1er avril 2011).
  6. Levy BS, Wegman DH, Baron SL, Sokas RK, editors. Occupational and environmental health: recognizing and preventing disease and injury. 6th ed. Oxford: Oxford University Press; 2011.
  7. Rogers B. Health hazards in nursing and health care: an overview. Am J Infect Control. 1997;25:248-61.
  8. Stellman JM, editor. Encyclopaedia of occupational health and safety (Lien externe) Site externe . 4th ed. (book on the internet). Geneva: International Labour Office; 1998 (cité le 1er avril 2011).
  9. Organisation mondiale de la Santé. Prévenir et combattre les maladies respiratoires aiguës à tendance épidémique ou pandémique dans le cadre des soins (Lien externe) Site externe WHO/CDS/EPR/2007.6. Genève : Organisation mondiale de la Santé; 2007 (cité le 1er avril 2011).
  10. Agence de la santé publique du Canada. Pratiques en matière d’hygiène des mains dans les milieux de soins (sous presse). 2011.
  11. Agence de la santé publique du Canada (auparavant Santé Canada). Guide de prévention des infections pour le lavage des mains, nettoyage, désinfection et stérilisation dans les établissements de santé. Document de la série des Guides de prévention des infections. Relevé des maladies transmissibles au Canada 1998;24S8:1-54.
  12. Valenti WM, Menegus MA. Nosocomial viral infections: IV. Guidelines for cohort isolation, the communicable disease survey, collection and transport of specimens for virus isolation, and considerations for the future. Infect Control 1981;2:236-45.
  13. Wells WF. On air-borne infection: II. Droplets and droplet nuclei. Am J Hyg 1934;20:611-8.
  14. Piper T, editor. Stedman's Medical Dictionary. 28th ed. Baltimore: Lippincott Williams & Wilkins; 2006.
  15. Canadian Standards Association. Selection, use and care of respirators (Z94.4-02 R2007). Toronto: Canadian Standards Association; 2003. Report No.: Z94.4-02 R2007.
  16. Dement J, Pompei L, Ostbye T, Epling C, Lipscomb H, James T, et al. An integrated comprehensive occupational surveillance system for health care workers. Am J Ind Med 2004;45:528-38.
  17. Agence de la santé publique du Canada, Comité consultatif national de l’immunisation. Guide canadien d’immunisation. 7e éd. Ottawa: Agence de la santé publique du Canada; 2006 (cité le 1er avril 2011).
  18. Comité consultatif national de l’immunisation (CCNI). Déclaration sur la vaccination antigrippale pour la saison 2007-2008. Relevé des maladies transmissibles au Canada 2008;33:23-4.
  19. Agence de la santé publique du Canada. Annexe G: Mesures et lignes directrices relatives aux soins cliniques. 2008 (cité le 1er avril 2011).
  20. National Institute for Occupational Health and Safety (NIOSH). NIOSH Respirator Selection Logic (Lien externe) Site externe PDF (en anglais seulement) (book on the internet). Cincinnati:NIOSH Publications Dissemination; 2004 (cité le 1er avril 2011).
  21. Heymann DL (ed.). Control of Communicable Diseases Manual, 19th ed. Washington, DC: American Public Health Association; 2008.
  22. Tang JWT, Tambyah PA, Lai FYL, Lee HK, Lee CK, Loh TP, et al. Differing Symptom Patterns in Early Pandemic vs. Seasonal Influenza Infections. Arch Intern Med 2010;170:861-7.
  23. Shiley KT, Nadolski G, Mickus T, Fishman NO, Lautenbach E. Differences in the Epidemiological Characteristics and Clinical Outcomes of Pandemic (H1N1) 2009 Influenza, Compared with Seasonal Influenza. Infect Control Hosp Epidemiol 2010;31:676-82.
  24. Harriman K, Rosenberg J, Robinson S, Bernier B, Bentz R, Waller K, et al. Novel Influenza A (H1N1) Virus Infection Among Health-Care Personnel, United States, April-May 2009. MMWR 2009;58:641-5.
  25. Patrozou E, Mermel L. Does influenza transmission occur from asymptomatic infection of prior to symptom onset? Public Health Rep 2009;124:193-6.
  26. Evans ME, Hall KL, Berry SE. Influenza control in acute care hospitals. Am J Infect Control 1997;25:357-62.
  27. Adal KA, Flowers RH, Anglim AM, Hayden FG, Titus MG, Coyner BJ, et al. Prevention of nosocomial influenza. Infect Control Hosp Epidemiol 1996;17:641-8.
  28. Pachucki CT, Walsh Pappas SA, Fuller GF, Krause SL, Lentino JR, Schaaff DM. Influenza A among hospital personnel and patients: implications for recognition, prevention, and control. Arch Intern Med 1989;149:77-80.
  29. Wilde J, McMillan J, Serwint J, Butta J, O'Riordan M, Steinhoff M. Effectiveness of influenza vaccine in health care professionals: a randomized trial. J Am Med Assoc 1999;281:908-13.
  30. Scheckler WE, Brimhall D, Buck AS, Farr BM, Friedman C, Garibaldi RA, et al. Requirements for infrastructure and essential activities of infection control and epidemiology in hospitals: a consensus panel report. Am J Infect Control 1998;26:47-60.
  31. Zoutman DE, Ford D, Bryce E, Gourdeau M, Hébert G, Henderson E, et al. The state of infection surveillance and control in Canadian acute care hospitals. Am J Infect Control 2003;31:266-73.
  32. Jackson MM, Fierer J, Barrett-Connor E, Fraser D, Klauber MR, Hatch R, et al. Intensive surveillance for infections in a three-year study of nursing home patients. Am J Epidemiol 1992;135:685-96.
  33. Haley RW, Culver DH, White JW, Morgan WM, Emori TG, Munn VP. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985;121:182-205.
  34. Venberghe A, Laterre P, Goenen M, Reynaert M, Wittebole X, Simon A, et al. Surveillance of hospital-acquired infections in an intensive care department-the benefit of the full-time presence of an infection control nurse. J Hosp Infect 2002;52:56-9.
  35. Morrison J. Development of a resource model for infection prevention and control programs in acute, long term, and home care settings: Conference proceedings of the infection prevention and control alliance. Am J Infect Control 2004;32:2-6.
  36. Comité consultatif provincial des maladies infectieuses (CCPMI). Pratiques exemplaires pour les programmes de prévention et de lutte contre les infections en Ontario dans tous les milieux de soins de santé. Toronto: Ministère de la Santé et des Soins de longue durée de l’Ontario; 2008 (cité le 1er avril 2011).
  37. Nichol KL, Margolis KL, Lind A, Murdock M, McFadden R, Hauge M, et al. Side effects associated with influenza vaccination in healthy working adults. Arch Intern Med 1996;156:1546-50.
  38. Lee MC, Takaya S, Joffe AM. Respirator fit-testing: Does it ensure the protection of healthcare workers against respirable particles carrying pathogens? Infect Control Hosp Epidemiol 2008;29:1149-56.
  39. Lee S-A, Grinshpun SA, Reponen T. Respiratory performance offered by N95 respirators and surgical masks: human subject evaluation with NaCl aerosol representing bacterial and viral particle size range. Ann Occup Hyg 2008;52:177-85.
  40. Last JM (editor). A dictionary of epidemiology. 4th ed. Oxford: Oxford University Press; 2001.
  41. Mausner JS, Kramer S. Mausner & Bahn Epidemiology: an introductory text. Philadelphia: W.B. Saunders Company; 1985.
  42. Vesley D, Streifel A. Environmental services. In: Mayhall CG, editor. Hospital epidemiology and infection control. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 1327-34.
  43. Musher DM. How contagious are common respiratory tract infections? New Eng J Med 2003;348:1256-66.
  44. Goldmann DA. Epidemiology and prevention of pediatric viral respiratory infections in health-care institutions. Emerg Infect Dis 2001;7:249-53.
  45. Roberts L, Smith W, Jorm L, Patel M, Douglas RM, McGilchrist C. Effect of infection control measures on the frequency of upper respiratory infection in child care: a randomized, controlled trial. Pediatr 2000;105:738-42.
  46. Xie X, Li Y, Chwang ATY, et al. How far droplets can move in indoor environments - revisiting the Wells evaporation-falling curve. Indoor Air 2007;17:211-25.
  47. Lindsley WG, Blachere FM, Davis KA, Pearce TA, Fisher MA, Khakoo R, et al. Distribution of Airborne Influenza Virus and Respiratory Syncytial Virus in an Urgent Care Medical Clinic. Clin Infect Dis 2010;50:693-8.
  48. Wan MP, Chao CYH, Ng YD, To GNS, Yu WC. Dispersion of Expiratory Droplets in a General Hospital Ward with Ceiling Mixing Type Mechanical Ventilation System. Aerosol Science and Technology 2007;41:244-58.
  49. Roy CJ, Milton DK. Airborne transmission of communicable infection - the elusive pathway. N Eng J Med 2004;350:1710-2.
  50. Brankston G. Transmission of influenza A in human beings. Lancet Infect Dis 2007;7:257-65.
  51. Jefferson T, Del Mar C, Dooley L, Ferroni E, Al-Ansary LA, Bawazeer GA, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Health Technology Assessment 2010;14(34):347-476.
  52. Bean B, Moore BM, Sterner B, Peterson LR, Gerding DN, Balfour HH. Survival of influenza viruses on environmental surfaces. J Infect Dis 1982;146:47-51.
  53. Hamburger M, Robertson OH. Expulsion of group A hemolytic streptococci in droplets and droplet nuclei by sneezing, coughing and talking. Am J Med 1948;4:690.
  54. Xie X, Li Y, Sun H, Liu L. Exhaled Droplets due to Talking and Coughing. J R Soc Interface 2009;6:S703-S714
  55. Fowler RA. Transmission of severe acute respiratory syndrome during intubation and mechanical ventilation. Am J Respir Crit Care Med 2004;169:1198-202.
  56. Beggs CB. The transmission of tuberculosis in confined spaces: an analytical review of alternative epidemiological models. Int J Tuberc Lung Dis 2003;7:1015-26.
  57. Lee B. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Eng J Med 2003;348:1986-94.
  58. Conseil des académies canadiennes. La transmission du virus de la grippe et la contribution de l’équipement de protection respiratoire individuelle – évaluation des données disponibles (Lien externe) Site externe PDF. Ottawa: Conseil des académies canadiennes; 2007 (cité le 1er avril 2011).
  59. Evans D. Epidemiology and etiology of occupational infectious disease. In: Couturier A, editor. Occupational and environmental infectious diseases: epidemiology, prevention and clinical management. Beverly Farms, MA: OEM Press; 2000. p. 37-132.
  60. Tang JW, Li Y, Eames I, Chan PKS, Ridgway GL. Factors involved in the aerosol transmission of infection and control of ventilation in healthcare premises. J Hosp Infect 2006;64:100-14.
  61. Scales DC, Green K, Chan AK, Poutanen S, Foster D, Nowak K, et al. Illness in intensive-care staff after brief exposure to severe acute respiratory syndrome. Emerg Infect Dis 2003;9:1205-10.
  62. Christian MD, Loutfy M, McDonald LC, Martinez KF, Ofner M, Wong T, et al. Possible SARS coronavirus transmission during cardiopulmonary resuscitation. Emerg Infect Dis 2004;10:287-93.
  63. Catanzaro A. Preventing nosocomial transmission of tuberculosis. Lancet 1995;345:204-5.
  64. Malasky C, Jordan T, Potulski F, Reichman LB. Occupational tuberculous infections among pulmonary physicians in training. Am Rev Respir Dis 1990;142:505-7.
  65. Larson JL, Ridzon R, Hannan MM. Sputum induction versus fiberoptic bronchoscopy in the diagnosis of tuberculosis. Am J Respir Crit Care Med 2001 Apr;163:1279-80.
  66. Yu I, Wong TW, Chiu Y. Temporal-spatial analysis of severe acute respiratory syndrome among hospital inpatients. Clin Infect Dis 2005;40:1237-43.
  67. Zhao Z, Zhang F, Xu M, Huang K, Zhong W, Cai W, et al. Description and clinical treatment of any early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. J Med Microbiol 2003;52:715-20.
  68. Kantor HS, Poblete R, Pusateri SL. Nosocomial transmission of tuberculosis from unsuspected disease. Am J Med 1988;84:833-8.
  69. Burton JL. Health and safety at necropsy. J Clin Pathol 2003;56:254-60.
  70. Yu I. Why did outbreaks of severe acute respiratory syndrome occur in some hospital wards but not in others? Clin Infect Dis 2007;44:1017-25.
  71. Blachere FM, Lindsley WG, Pearce TA, Anderson SE, Fisher M, Khakoo R, et al. Measurement of Airborne Influenza Virus in a Hospital Emergency Department. Clin Infect Dis 2009;48:438-40.
  72. Fabian P, McDevitt JJ, DeHaan WH, Fung ROP, Cowling BJ, et al. Influenza virus in human exhaled breath: An observational study (Lien externe) Site externe (en anglais seulement). PLoS ONE (serial on the internet). 3(7): e2691. doi:10.1371/journal.pone.0002691.
  73. Feigin RD, Baker C, Herwaldt LA, Lampe RM, Mason EO, Whitney SE. Epidemic meningococcal disease in an elementary-school classroom. N Eng J Med 1982;307:1255-7.
  74. Bamberg W, Finkner N, Simmerly D, Clement E, Kogut S, Schaffzin JK, et al. Outbreaks of 2009 Pandemic Influenza A (H1N1) Among Long-Term Care Facility Residents - Three States, 2009. MMWR 2010;59:74-7.
  75. Facility Guidelines Institute (Lien externe) Site externe (en anglais seulement), US Department of Health and Human Services. Guidelines for Design and Construction of Health Care Facilities (book on the internet). Chicago: American Society for Healthcare Engineering; 2010 (cité le 1er avril 2011).
  76. Agence de la santé publique du Canada (auparavant Santé Canada). Infections nosocomiales chez les patients d’établissements de santé liées aux travaux de construction : atténuer le risque d’aspergillose, de légionellose et d’autres infections. Relevé des maladies transmissibles au Canada 2001(supp);27S2:1-42.
  77. Canadian Standards Association. Special requirements for heating, ventilation, and air conditioning (HVAC) systems in health care facilities (Z317.2-10). Toronto: Canadian Standards Association; 2010. Report No.: Z317.2-10.
  78. Raterman S. Methods of control. In: Plog BA, editor. Fundamentals of industrial hygiene. 5th ed. Itasca, Il: National Safety Council; 2002. p. 585-606.
  79. Grayson ML, Melvani S, Druce J, Barr IG, Ballard SA, Johnson DR, et al. Efficacy of soap and water and alcohol-based hand-rub preparations against live H1N1 influenza virus on the hands of human volunteers. Clin Infect Dis 2009;48:285-91.
  80. Gralton J, McLaws ML. Protecting Healthcare Workers for Pandemic Influenza: N95 or Surgical Masks? Crit Care Med 2010;38:657-67.
  81. Loeb M, Dafoe N, Mahony J, John M, Sarabia A, Glavin V, et al. Surgical Mask Versus N95 Respirator for Preventing Influenza: A Randomized Trial. J Am Med Assoc 2009;302:1865-71.
  82. Ang B, Poh BF, Win MK, Chow A. Surgical Masks for Protection of Health Care Personnel Against Pandemic Novel Swine-Origin Influenza A (H1N1) - 2009: Results from an Observational Study. Clin Infect Dis 2010;50:1011-4.
  83. Chen S, Vesley D, Brosseau LM, Vincent J. Evaluation of single-use masks and respirators for protection of health care workers against mycobacterial aerosols. Am J Infect Control 1994;22:65-74.
  84. McCullough NV, Brosseau LM, Vesley D. Collection of three bacterial aerosols by respirator and surgical mask filters under varying conditions of flow and relative humidity. Ann Occup Hyg 1997;41:677-90.
  85. Rhame FS. The inanimate environment. In: Bennett JV, editor. Hospital infections. 4th ed. Philadelphia: Lippincott-Raven; 1998. p. 299-324.
  86. Collins BJ. The hospital environment: how clean should a hospital be? J Hosp Infect 1988;11 (Supp. A):53-6.
  87. Lior L, Litt M, Hockin J, Kennedy C, Jolley BA, Garcia M, et coll. Découverte d’entérocoques résistant à la vancomycine dans un service de néphrologie d’un hôpital Ontarien. Relevé des maladies transmissibles au Canada 1996;22:125-8.
  88. Phin NF, Rylands AJ, Allan J, Edwards C, Enstone JE, Nguyen-Van-Tam JS. Personal protective equipment in an influenza pandemic: a UK simulation exercise. J Hosp Infect 2009;71:15-21.
  89. Lau JT. SARS transmission among hospital workers in Hong Kong. Emerg Infect Dis 2004;10:280-6.
  90. Gamage B, Moore D, Copes R, Yassi A, Bryce E, Interdisciplinary Respiratory Protection Study Group. Protecting health care workers from SARS and other respiratory pathogens: A review of the infection control literature. Am J Infect Control 2005;33:114-21.
  91. Seto WH, Tsang D, Yung RW, Ching TY, Ng TK, Ho LM, et al. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet 2003;361:1519-20.
  92. Chia S. Appropriate use of personal protective equipment among healthcare workers in public sector hospitals and primary healthcare polyclinics during the SARS outbreak in Singapore. Occup Environ Med 2005;62:473-7.
  93. Rengasamy A. Respiratory protection against bioaerosols: literature review and research needs. Am J Infect Control 2004;32:345-54.
  94. National Academy of Sciences, editor. Reusability of facemasks during an influenza pandemic - facing the flu (Lien externe) Site externe (en anglais seulement). Washington: The National Academies Press, 2006 (cité le 1er avril 2011).
  95. Lai MY, Cheng P, Lim W. Survival of severe acute respiratory syndrome coronavirus. Clin Infect Dis 2005;41:67-71.
  96. Garner JS. Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol 1996;17:54-80.
  97. Cassells JM, Redman BK. New baccalaureate graduates in care of AIDS patients: perceptions of preparedness and information accessibility. J Cont Educ Nurs 1989;20:156-61.
  98. The spread of EMRSA-16. Relevé des maladies transmissibles au Canada hebdomadaire 1993;3:121-4.
  99. International Organization for Standardization. An introduction to information, network and internet security: Appendix G - Risk Terms and Definitions (Lien externe) Site externe (en anglais seulement). Geneva: International Organization for Standardization; 2005. Report No.: ISO 27001.
  100. Glezen WP. Emerging infections: pandemic influenza. Epidemiol Rev 1996;18:64-76.
  101. Carman WF, Elder AG, Wallace LA, McAulay K, Walker A, Murray GD, et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet 2000;355(93):97.
  102. Potter J, Stott DJ, Roberts MA, Elder AG, O'Donnell B, Knight PV, et al. Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis 1997;175:1-6.
  103. Agence de la santé publique du Canada (auparavant Santé Canada). La prévention des infections transmissibles par le sang dans les établissements de santé et les services publics. Relevé des maladies transmissibles au Canada 1997(supp);23S3:1-43.
  104. Nicolle L, Perkins P, Gravel D, Paton S, Christian M, Ofner M, et coll. Prise en charge des patients atteints du syndrome respiratoire aigu sévère (SRAS) dans les établissements des soins actifs de la région du grand Toronto. Relevé des maladies transmissibles au Canada 2008;34:1-13.
  105. Bloch AB, Orenstein WA, Ewing WM, Spain WH, Mallison GF, Herrmann KL, et al. Measles outbreak in a pediatric practice: airborne transmission in an office setting. Pediatrics 1985;75:676-83.
  106. Zoutman DE, Ford BD, Canadian Hospital Epidemiology Committee, Canadian Nosocomial Infection Surveillance Program, Health Canada. The relationship between hospital infection surveillance and control activities and antibiotic-resistant pathogen rates. Am J Infect Control 2005;33(1):1-5.
  107. Organisation mondiale de la Santé. Rapport 2009 sur la lutte contre la tuberculose dans le monde (Lien externe) Site externe WHO/HTM/TB/2009.411. Genève: Organisation mondiale de la Santé; 2009 (cité le 1er avril 2011).
  108. Sehulster L, Chinn RYW. Guidelines for environmental infection control in health-care facilities. MMWR 2003;52(RR-10):1-44.
  109. Canadian Standards Association. Decontamination of reusable medical devices (Z314.8-08). Toronto: Canadian Standards Association; 2008. Report No.: Z314.8-08.
  110. Canadian Standards Association. Steam Sterilizers for Health Care Facilities (Z314.7-03 R2008). Toronto: Canadian Standards Association; 2003. Report No.: Z314.7-03.
  111. Canadian Standards Association. Effective sterilization in health care facilities by the steam process (Z314.3-09). Toronto: Canadian Standards Association; 2009. Report No.: Z314.3-09.
  112. Canadian Standards Association. Sterilization of health care products - general requirements for characterization of a sterilizing agent and the development, validation and routine control of a sterilization process for medical devices. Toronto: Canadian Standards Association; 2001. Report No.: CAN/CSA-ISO 14937-01.
  113. Canadian Standards Association. Sterilization of health care products - Chemical indicators - Guidance for selection, use and interpretation of results (CSA Z15882-09). Toronto: Canadian Standards Association; 2009. Report No.: Z15882-09.
  114. Canadian Standards Association. Sterilization of health care products - Chemical indicators Part 1: General requirements (CSA Z11140-1-07). Toronto: Canadian Standards Association; 2007. Report No.: Z11140-1-07.
  115. Nelson JD. Jails, microbes and the three-foot barrier. N Eng J Med 1996;335:885-6.
  116. Arnow PM, Andersen RL, Mainous PD, Smith EJ. Pulmonary aspergillosis during hospital renovation. Am Rev Respir Dis 1978;118:49-53.
  117. Brundage JF, Scott RM, Lednar WM, Smith DW, Miller RN. Building-associated risk of febrile acute respiratory diseases in Army trainees. J Am Med Assoc 1998 Apr 8;259:2108-12.
  118. Agence de la santé publique du Canada. (Page d’accueil). Ottawa: Agence de la santé publique du Canada (cité le 1er avril 2011).
  119. Comité consultatif provincial des maladies infectieuses. Annexe L: Étapes recommandées pour la mise en place et le retrait du matériel de protection individuelle (MPI). Dans: Pratiques de base et précautions supplémentaires dans tous les établissements de soins de santé. Ministère de la Santé et des Soins de longue durée de l’Ontario. Toronto: Ministère de la Santé et des Soins de longue durée de l’Ontario; 2010 (cité le 1er avril 2011).

[Page précédente] [Table des matières]

Date de modification : 2011-09-01

Haut de la page
Avis importants